AIIMS director hails DCGI approval of 'India-made' COVID vaccine
"It is a great moment for India and for our fight against COVID-19. Bharat Biotech's Covaxin is a vaccine that has been made in India. A matter of pride for the whole country," says Delhi AIIMS director Dr. Randeep Guleria on DCGI nod to coronavirus vaccines. Listen-in.
READ MORE:
Other Healthcare/Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
